HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epstein-Barr virus is not detected in mucosal lichen planus.

AbstractBACKGROUND:
Lichen planus (LP) is a chronic inflammatory, immunological, mucocutaneous disease can affect skin, genital and oral mucosa. Oral lichen planus (OLP) is the most common noninfectious, chronic inflammatory oral disease affecting 1-2% of the general adult population. World Health Organization (WHO) classifies OLP as a potentially malignant disorder. Epstein Barr virus or human herpesvirus-4, is a member of the herpes virus family and one of the most ubiquitous viruses known to human, infecting approximately 90% of the world's adult population. The virus often infects B lymphocytes resulting in a wide spectrum of mucocutaneous and systemic diseases, ranging from mild lesions to aggressive malignancies. The aim of this study was to investigate expression of the EBV encoded RNAs EBER1 and EBER2 in oral and genital lichen planus and compare results with normal tissues in situ hybridization which is considered the golden standard for detection of EBER.
MATERIAL AND METHODS:
A total of 68 biopsies, 25 oral LP, 26 genital LP, 10 oral controls and finally 7 genital controls were analysed using situ hybridization.
RESULT:
All samples had RNA as shown by the control slide, whereas no case contained neither EBER1 nor EBER2.
CONCLUSIONS:
Based on results from our study EBV is not involved in aetiology of lichen planus.
AuthorsK Danielsson, E Nylander, M Sjöström, M Ebrahimi
JournalMedicina oral, patologia oral y cirugia bucal (Med Oral Patol Oral Cir Bucal) Vol. 23 Issue 5 Pg. e560-e563 (Sep 01 2018) ISSN: 1698-6946 [Electronic] Spain
PMID30148472 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Herpesvirus 4, Human (isolation & purification)
  • Humans
  • Lichen Planus (virology)
  • Male
  • Middle Aged
  • Mucous Membrane (virology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: